---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/100000000798668.md"
description: "BofA: ASML $ASML(ASML.US) Major Estimate Upgrades (CY26–28E)Following a strong Q2 earnings print, BofA materially upgraded its financial estimates:  > Revenue Estimates: Raised by 13% to 15% across CY26–28E. This is driven by higher Argon Fluoride Immersion (ArFi) units/ASPs, higher Extreme Ultraviolet (EUV) ASPs, and higher Installed Base Management revenues.  > Gross Margin (GM): Upgraded by 2.2 to 3.3 percentage points. This structural improvement is backed by a richer mix of ArFi and EUV tools, higher software revenues, and increased upgrade contributions.  > Earnings Per Share (EPS): Upgraded significantly across the forecast horizon:  2026E EPS: Raised to €41.49 (previously €33.17, up 25%).  2027E EPS: Raised to €58.16 (previously €46.75, up 24%).  2028E EPS: Raised to €75.43 (previously €62.31, up 21%).> Memory Dominance: ASML’s guided CY26E memory revenue growth of 75% is expected to far outpace US peers, driven by the DRAM industry's structural transition to EUV.  > Rising Tool Prices (ASPs): Low-NA EUV tool average selling prices (ASPs) are projected to climb to €245m in 2H26E (compared to €220–230m in H1), indicating stronger software attach rates.  > Constrained OPEX: Operating expenses are expected to grow materially slower than group revenues due to operational efficiencies.  > Confidence Beyond 2027: While the market is highly focused on ASML's 85 EUV unit target for 2027, management is confident in potentially scaling capacity to 110 EUV units beyond 2027."
datetime: "2026-07-15T23:52:04.000Z"
locales:
  - [en](https://longbridge.com/en/topics/100000000798668.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/100000000798668.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/100000000798668.md)
author: "[Equity research](https://longbridge.com/en/profiles/2071818324550963200.md)"
generator: "portal-rs"
---

# BofA: ASML $ASML(ASML.US) Major Estimate Upgrades …


### Related Stocks

- [ASML.US](https://longbridge.com/en/quote/ASML.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md)
- [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md)
- [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md)
- [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md)
- [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md)
- [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md)
- [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md)
- [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**